Steven Hancock

Publications

• Automatic Prostate Tracking and Motion Assessment in Volumetric Modulated Arc Therapy With an Electronic Portal Imaging Device. Azcona JD, Li R, Mok E, Hancock S, Xing L. Int J Radiat Oncol Biol Phys. 2013
• Development and clinical evaluation of automatic fiducial detection for tumor tracking in cine megavoltage images during volumetric modulated arc therapy. Azcona JD, Li R, Mok E, Hancock S, Xing L. Med Phys. 2013; 40 (3): 031708
• Esophageal tolerance to high-dose stereotactic ablative radiotherapy. Abelson JA, Murphy JD, Loo BW, Chang DT, Daly ME, Wiegner EA, Hancock S, Chang SD, Le QT, Soltys SG, Gibbs IC. Dis Esophagus. 2012 Sep-Oct; 25 (7): 623-9
• Testicular cancer. Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Wang J, Wilder RB. J Natl Compr Canc Netw. 2012; 10 (4): 502-35
• Kidney cancer. Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Carducci MA, Chang SS, Choueiri TK, Hancock SL, Hudes GR, Jonasch E, Josephson D, Kuzel TM, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Spiess PE, Wang J, Wilder RB. J Natl Compr Canc Netw. 2011; 9 (9): 960-77
• Clinical development of a failure detection-based online repositioning strategy for prostate IMRT--experiments, simulation, and dosimetry study. Liu W, Qian J, Hancock SL, Xing L, Luxton G. Med Phys. 2010; 37 (10): 5287-97
• NCCN clinical practice guidelines in oncology: kidney cancer. Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwartz LH, Sheinfeld J, Wang J. J Natl Compr Canc Netw. 2009; 7 (6): 618-30
• NCCN clinical practice guidelines in oncology: testicular cancer. Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwartz LH, Sheinfeld J, Wang J. J Natl Compr Canc Netw. 2009; 7 (6): 672-93
• Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease. Kwong A, Hancock SL, Bloom JR, Pal S, Birdwell RL, Mariscal C, Ikeda DM. Breast J. 2008 Jan-Feb; 14 (1): 39-48
• A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Ho AK, Fu D, Cotrutz C, Hancock SL, Chang SD, Gibbs IC, Maurer CR, Adler JR. Neurosurgery. 2007; 60 (2 Suppl 1): ONS147-56; discussion ONS156
• Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients. Spiotto MT, Hancock SL, King CR. Int J Radiat Oncol Biol Phys. 2007; 69 (1): 54-61
• Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, Tate DJ, Horning SJ, Hoppe RT, Hancock SL. J Clin Oncol. 2007; 25 (1): 43-9
• Breast cancer screening in women surviving Hodgkin disease. Bloom JR, Stewart SL, Hancock SL. Am J Clin Oncol. 2006; 29 (3): 258-66
• Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose irradiation. Patel DA, Kochanski J, Suen AW, Fajardo LF, Hancock SL, Knox SJ. Cancer. 2006; 106 (3): 718-25
• Kidney cancer. Clinical practice guidelines in oncology. Motzer RJ, Bolger GB, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Jonasch E, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pohar K, Redman BG, Robertson CN, Samlowski WE, Sheinfeld J. J Natl Compr Canc Netw. 2006; 4 (10): 1072-81
• Testicular cancer. Clinical practice guidelines in oncology. Motzer RJ, Bolger GB, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Jonasch E, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pohar KS, Redman BG, Robertson CN, Samlowski WE, Sheinfeld J. J Natl Compr Canc Netw. 2006; 4 (10): 1038-58
• Diastolic dysfunction after mediastinal irradiation. Heidenreich PA, Hancock SL, Vagelos RH, Lee BK, Schnittger I. Am Heart J. 2005; 150 (5): 977-82
• Kidney cancer. Clinical practice guidelines. Motzer RJ, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pili R, Pohar KS, Redman BG, Richey S, Robertson CN, Samlowski WE, Sheinfeld J, Urban DA. J Natl Compr Canc Netw. 2005; 3 (1): 84-93
• Metabolism of the 16-androstene steroids in primary cultured porcine hepatocytes. Sinclair PA, Hancock S, Gilmore WJ, Squires EJ. J Steroid Biochem Mol Biol. 2005; 96 (1): 79-87
• Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy. Mauch P, Ng A, Aleman B, Carde P, Constine L, Diehl V, Dinshaw K, Gospodarowicz M, Hancock S, Hodgson D, Hoppe R, Liang R, Loeffler M, Specht L, Travis LB, Wirth A, Yahalom J. Eur J Haematol Suppl. 2005; (66): 68-76
• Testicular cancer. Clinical practice guidelines. Motzer RJ, Bahnson RR, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Redman BG, Richey S, Robertson CN, Samlowski WE, Sheinfeld J, Urban DA. J Natl Compr Canc Netw. 2005; 3 (1): 52-76
• A systolic murmur is a common presentation of aortic regurgitation detected by echocardiography. Heidenreich PA, Schnittger I, Hancock SL, Atwood JE. Clin Cardiol. 2004; 27 (9): 502-6
• Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Luxton G, Hancock SL, Boyer AL. Int J Radiat Oncol Biol Phys. 2004; 59 (1): 267-84
• Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes? King CR, Presti JC, Gill H, Brooks J, Hancock SL. Int J Radiat Oncol Biol Phys. 2004; 59 (2): 341-7
• Asymptomatic cardiac disease following mediastinal irradiation. Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. J Am Coll Cardiol. 2003; 42 (4): 743-9
• Post-irradiation polyradiculopathy mimics leptomeningeal tumor on MRI. Hsia AW, Katz JS, Hancock SL, Peterson K. Neurology. 2003; 60 (10): 1694-6
• Role of beam orientation optimization in intensity-modulated radiation therapy. Pugachev A, Li JG, Boyer AL, Hancock SL, Le QT, Donaldson SS, Xing L. Int J Radiat Oncol Biol Phys. 2001; 50 (2): 551-60
• Hodgkin's Lymphoma: Choice of Therapy and Late Complications. Linch DC, Gosden RG, Tulandi T, Tan SL, Hancock SL. Hematology Am Soc Hematol Educ Program. 2000: 205-221
• Management of breast cancer after Hodgkin's disease. Wolden SL, Hancock SL, Carlson RW, Goffinet DR, Jeffrey SS, Hoppe RT. J Clin Oncol. 2000; 18 (4): 765-72
• The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects. Donaldson SS, Hancock SL, Hoppe RT. Cancer J Sci Am. 1999 Nov-Dec; 5 (6): 325-33
• Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: a preliminary report. Poen JC, Golby AJ, Forster KM, Martin DP, Chinn DM, Hancock SL, Adler JR. Neurosurgery. 1999; 45 (6): 1299-305; discussion 1305-7
• Image-guided robotic radiosurgery Adler JR, Murphy MJ, Chang SD, Hancock SL. Neurosurgery. 1999; 44 (6): 1299-306; discussion 1306-7
• Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, Kuban DA, Hancock SL, Smith CD. JAMA. 1999; 281 (17): 1598-604
• Treatment of cavernous sinus tumors with linear accelerator radiosurgery. Chang SD, Doty JR, Martin DP, Hancock SL, Adler JR. Skull Base Surg. 1999; 9 (3): 195-200
• Acute hearing loss following fractionated stereotactic radiosurgery for acoustic neuroma. Report of two cases. Chang SD, Poen J, Hancock SL, Martin DP, Adler JR. J Neurosurg. 1998; 89 (2): 321-5
• Clinical experience with image-guided robotic radiosurgery (the Cyberknife) in the treatment of brain and spinal cord tumors. Chang SD, Murphy M, Geis P, Martin DP, Hancock SL, Doty JR, Adler JR. Neurol Med Chir (Tokyo). 1998; 38 (11): 780-3
• Clinical uses of radiosurgery. Chang SD, Adler JR, Hancock SL. Oncology (Williston Park). 1998; 12 (8): 1181-8, 1191; discussion 1191-2
• Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer. Eulau SM, Tate DJ, Stamey TA, Bagshaw MA, Hancock SL. Int J Radiat Oncol Biol Phys. 1998; 41 (4): 735-40
• Node-positive prostatic cancer: taps or a call to arms? Hancock SL, Int J Radiat Oncol Biol Phys. 1998; 40 (4): 757-9
• Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol) Gross C, Stamey T, Hancock S, Feldman D. J Urol. 1998; 159 (6): 2035-9; discussion 2039-40
• Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Chang SD, Meisel JA, Hancock SL, Martin DP, McManus M, Adler JR. Neurosurgery. 1998; 43 (1): 28-34; discussion 34-5
• Gastrointestinal cancer after treatment of Hodgkin's disease. Birdwell SH, Hancock SL, Varghese A, Cox RS, Hoppe RT. Int J Radiat Oncol Biol Phys. 1997; 37 (1): 67-73
• Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. Horning SJ, Hoppe RT, Mason J, Brown BW, Hancock SL, Baer D, Rosenberg SA. J Clin Oncol. 1997; 15 (5): 1736-44
• The Cyberknife: a frameless robotic system for radiosurgery. Adler JR, Chang SD, Murphy MJ, Doty J, Geis P, Hancock SL. Stereotact Funct Neurosurg. 1997; 69 (1-4 Pt 2): 124-8
• Linear accelerator-based stereotaxic radiosurgery for brain metastases:the influence of number of lesions on survival. Joseph J, Adler JR, Cox RS, Hancock SL. J Clin Oncol. 1996; 14 (4): 1085-92
• Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. Hancock SL, Hoppe RT. Semin Radiat Oncol. 1996; 6 (3): 225-242
• Second cancers after Hodgkin's disease in childhood. Donaldson SS, Hancock SL. N Engl J Med. 1996; 334 (12): 792-4
• Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report. Bartlett NL, Rosenberg SA, Hoppe RT, Hancock SL, Horning SJ. J Clin Oncol. 1995; 13 (5): 1080-8
• Prostate specific antigen after radiotherapy for prostate cancer: a reevaluation of long-term biochemical control and the kinetics of recurrence in patients treated at Stanford University. Hancock SL, Cox RS, Bagshaw MA. J Urol. 1995; 154 (4): 1412-7
• Stem cell factor enhances the survival of murine intestinal stem cells after photon irradiation. Leigh BR, Khan W, Hancock SL, Knox SJ. Radiat Res. 1995; 142 (1): 12-5
• Thyroid abnormalities after therapeutic external radiation. Hancock SL, McDougall IR, Constine LS. Int J Radiat Oncol Biol Phys. 1995; 31 (5): 1165-70
• Computed tomography assessment of splenic size as a predictor of splenic weight and disease involvement in laparotomy staged Hodgkin's disease. Hancock SL, Scidmore NS, Hopkins KL, Cox RS, Bergin CJ. Int J Radiat Oncol Biol Phys. 1994; 28 (1): 93-9
• Control of prostate cancer with radiotherapy: long-term results. Bagshaw MA, Cox RS, Hancock SL. J Urol. 1994; 152 (5 Pt 2): 1781-5
• Stem cell factor enhances the survival of irradiated human bone marrow maintained in SCID mice. Leigh BR, Webb S, Hancock SL, Knox SJ. Stem Cells. 1994; 12 (4): 430-5
• Breast cancer after treatment of Hodgkin's disease. Hancock SL, Tucker MA, Hoppe RT. J Natl Cancer Inst. 1993; 85 (1): 25-31
• Cardiac disease following treatment of Hodgkin's disease in children and adolescents. Hancock SL, Donaldson SS, Hoppe RT. J Clin Oncol. 1993; 11 (7): 1208-15
• Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. Hancock SL, Tucker MA, Hoppe RT. JAMA. 1993; 270 (16): 1949-55
• Radiation or surgery for carcinoma of the esophagus: the role of organ-conserving therapy. Hancock SL, Front Radiat Ther Oncol. 1993: 27 103-17
• The effect of stem cell factor on irradiated human bone marrow. Leigh BR, Hancock SL, Knox SJ. Cancer Res. 1993; 53 (17): 3857-9
• Interleukin 1 beta initially sensitizes and subsequently protects murine intestinal stem cells exposed to photon radiation. Hancock SL, Chung RT, Cox RS, Kallman RF. Cancer Res. 1991; 51 (9): 2280-5
• Thyroid diseases after treatment of Hodgkin's disease. Hancock SL, Cox RS, McDougall IR. N Engl J Med. 1991; 325 (9): 599-605
• Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03. Coleman CN, Wasserman TH, Urtasun RC, Halsey J, Noll L, Hancock S, Phillips TL. Int J Radiat Oncol Biol Phys. 1990; 18 (2): 389-93
• Current Stanford clinical trials for Hodgkin's disease. Hoppe RT, Horning SJ, Hancock SL, Rosenberg SA. Recent Results Cancer Res. 1989: 117 182-90
• Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials. Hancock SL, Hoppe RT, Horning SJ, Rosenberg SA. Ann Intern Med. 1988; 109 (3): 183-9
• Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease. Horning SJ, Hoppe RT, Hancock SL, Rosenberg SA. J Clin Oncol. 1988; 6 (12): 1822-31